SCHEMBL30229368

SCHEMBL30229368

O=Cc1cc2c(F)cccc2n1S(=O)(=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 2/20 0.42
▸ NOD1 Q9Y239 2/20 0.40
▸ CXCL8 P10145 1/20 0.40
▸ PTGDR Q13258 1/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ HTR6 P50406 11/20 0.39
▸ FABP4 P15090 1/20 0.37
▸ HTR1A P08908 2/20 0.36
▸ HTR1D P28221 2/20 0.36
▸ HTR1B P28222 2/20 0.36
▸ HTR1F P30939 2/20 0.36
▸ HTR7 P34969 2/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839545 1.00 SRC (0.42) SRCNOD1CXCL8PTGDRPTGDR2
SCHEMBL16796191 0.81 CNR2 (0.43) SRCNOD1CXCL8HTR6
SCHEMBL25422879 0.80 MTNR1B (0.55) SRCHTR6FABP4
SCHEMBL20841436 0.79 SRC (0.40) SRCNOD1CXCL8PTGDRPTGDR2
SCHEMBL30276218 0.78 CA12 (0.52) SRCNOD1CXCL8HTR6CA12
SCHEMBL369194 0.78 CA12 (0.52) SRCNOD1CXCL8HTR6CA12
SCHEMBL16795088 0.76 SRC (0.40) SRCNOD1CXCL8HTR6HTR1A
SCHEMBL20853109 0.75 PTGDR2 (0.42) SRCNOD1CXCL8PTGDRPTGDR2
SCHEMBL17927607 0.75 ACLY (0.44) SRCNOD1PTGDRPTGDR2HTR6
SCHEMBL30158830 0.75 SRC (0.37) SRCNOD1CXCL8PTGDRPTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111108105-B Heterocyclic compounds as PAD inhibitors 朱比兰特埃皮帕德有限公司 2023-03-31 — — CN disclosed
CN-111225915-B Imidazopyridine compounds as PAD inhibitors 朱比兰特埃皮帕德有限公司 2023-03-07 — — CN disclosed
Send feedback